Joseph K. Belanoff, CHIEF EXECUTIVE OFFICER at CORCEPT THERAPEUTICS INC (CORT), sold 500,000 shares at $9.10 ($4.5M) on 2016-11-11, disclosed to the SEC on 2016-11-14.
Open-market sale of $4.5M CORT by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.90 | 300,000 | $2.7M | 59.5% |
| 2 | $9.10 | 200,000 | $1.8M | 40.5% |
| Total | $8.98 avg | 500,000 | $4.5M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |